EICHOR
● Recruiting
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Condition: Type 1 Diabetes Mellitus · Sponsor: Sanofi
About this study
This is a multicenter, randomized, double-blind, parallel, placebo-controlled Phase 3, 2-arm study for treatment. The purpose of this study is to measure change in glycemic control and prandial insulin independency over 52 weeks with teplizumab compared with placebo, both administered by intravenous (IV) infusion, in participants with recently diagnosed Stage 3 type 1 diabetes (T1D) aged 1 to 25 years, on standard insulin therapy.
This description comes directly from the study's public registry record.
Talk to the study team
Trial Transparency email recommended (Toll free for US & Canada) · 800-633-1610 · contact-us@sanofi.com
Always discuss trial participation with your own doctor first.
Locations (161)
| Scottsdale Clinical Trials- Site Number : 8400044 | Scottsdale, Arizona, United States | Recruiting |
| Marvel Clinical Research- Site Number : 8400042 | Huntington Beach, California, United States | Recruiting |
| University of California San Francisco - Mission Bay- Site Number : 8400011 | San Francisco, California, United States | Recruiting |
| Barbara Davis Center for Childhood Diabetes- Site Number : 8400031 | Aurora, Colorado, United States | Recruiting |
| Yale University School of Medicine- Site Number : 8400005 | New Haven, Connecticut, United States | Recruiting |
| University of Florida College of Medicine- Site Number : 8400054 | Gainesville, Florida, United States | Recruiting |
| Encore Medical Research - Hollywood- Site Number : 8400061 | Hollywood, Florida, United States | Recruiting |
| University of South Florida- Site Number : 8400013 | Tampa, Florida, United States | Recruiting |
| AdventHealth Winter Park- Site Number : 8400033 | Winter Park, Florida, United States | Recruiting |
| Atlanta Diabetes Associates- Site Number : 8400036 | Atlanta, Georgia, United States | Recruiting |
| IACT Health - Columbus - Talbotton Road- Site Number : 8400003 | Columbus, Georgia, United States | Recruiting |
| Institute of Endocrinology Diabetes, Health & Hormones- Site Number : 8400050 | Stockbridge, Georgia, United States | Recruiting |
+ 149 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07088068